P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL). (23rd June 2022) - Kadia, T.; Ravandi, F.; Borthakur, G.; Jabbour, E.; Montalban-Bravo, G.; Adewale, L.; Pierce, S.; Lacke, C.; Brandt, M.; Short, N.; Jain, N.; Burger, J.; et al.